Soc. Generale Call 94 SRE 20.03.2.../ DE000SU5XF55 /
14/06/2024 10:04:04 | Var.+0.010 | Denaro14/06/2024 | Lettera14/06/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.280EUR | +3.70% | 0.280 Quantità in denaro: 10,000 |
0.380 Quantità in lettera: 10,000 |
Sempra | 94.00 USD | 20/03/2026 | Call |
GlobeNewswire
09:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...